Real-world Data Collection of Microvention Devices for Treating Intracranial Aneurysms and Acute Ischemic Stroke

What this Trial Is About

This research aims to collect real-world clinical data on the use of commercially approved Microvention devices for treating intracranial aneurysms and acute ischemic stroke. It is a post-market, single-arm, non-interventional, multicenter registry designed to evaluate and report the safety and effectiveness of these devices as used in everyday clinical practice. Participants are grouped into two cohorts one includes patients treated with Microvention Class III implantable devices for ruptured or unruptured intracranial aneurysms, and the other includes patients treated with Microvention Class III mechanical thrombectomy devices for acute ischemic stroke. The devices are used as the primary treatment chosen by the treating physician outside of this study. The study focuses on devices that are CE marked and commercially available. During the study, data will be collected electronically on patient outcomes and device performance. Key measurements include the proportion of aneurysms completely occluded at approximately 18 months for Cohort 1, and the proportion of patients achieving successful revascularization during mechanical thrombectomy procedures for Cohort 2. Follow-up and data collection continue as participants receive standard care, with the study observing outcomes without altering treatment. Participant involvement includes consent for data collection and monitoring through routine clinical follow-up.

Microvention AnEurysm & STroke Real-life Data cOllection